FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
K18 The Effects of pH on the Oxidation of<br />
Ephedrine and Phenylpropanolamine<br />
Using Sodium Periodate<br />
Neil A. Fortner, MS*, Roger Rutter, BS, and Joseph Lane, BS,<br />
PharmChem, Inc., 4600 North Beach, Haltom City, TX 76137;<br />
Robert F. Turk, PhD, Center for Toxicology Services, Inc., 8231<br />
Lakeshore Villa Drive, Humble, TX 77346<br />
The attendees will better understand the impact that pH may have<br />
on the oxidation of ephedrine and phenylpropanolamine using sodium<br />
periodate.<br />
The use of sodium periodate to chemically oxidize common over<br />
the counter amphetamine like substances such as ephedrine, and phenylpropanolamine<br />
has become an accepted practice in forensic urine drug<br />
testing environments. However, very little information is available as to<br />
the effect that pH has on the efficiency of this oxidative procedure. The<br />
purpose of this study was to evaluate the potential of the production of<br />
amphetamine and methamphetamine in the presence of high concentrations<br />
(3,000,000 ng/ml) of ephedrine and phenylpropanolamine. A saturated<br />
sodium periodate solution and sodium hydroxide solution are<br />
added to the urine sample containing the drug and deuterated internal<br />
standards. The pH of this oxidation step is between 11 and 13. In this<br />
study, the sodium periodate was also adjusted to pH 4.4, 5.2, 9.1 and 9.3.<br />
Samples were extracted using solid phase technology, and derivatized<br />
with MBTFA to form the TFA derivative. GC/MS analysis was conducted<br />
using electron impact ionization using three ions for the native<br />
compound and two ions for the deuterated internal standard. A single<br />
point calibrator at 500 ng/ml was used to establish both qualitative and<br />
quantitative results. No amphetamine or methamphetamine was detected<br />
at any of the pH levels evaluated. This data suggests that the oxidation<br />
of ephedrine and phenylpropanolamine at levels as high as 3,000,000<br />
ng/ml by sodium periodate is effective when the pH is between 4.4<br />
and 13.<br />
pH, Ephedrine, Phenylpropanolamine<br />
K19 The Validity of Surrogate<br />
Reporting of Substance Use<br />
Hsiang-Ching Kung, PhD* and Jack Li, PhD, National Center for<br />
Health Statistics, CDC, 3311 Toledo Road, Room 7318, Hyattsville,<br />
MD 20782; Rong-Jen Hwang, PhD, Toxicology Laboratory Criminal<br />
Investigations Division, Santa Barbara County Sheriff-Coroner, 66<br />
South San Antonio Road, Santa Barbara, CA 93110<br />
After attending this presentation, attendees will have an understanding<br />
of evaluating the validity of surrogate reporting of substance<br />
use for the deceased.This study contribute to the understanding of<br />
factors involved in achieving high sensitivity and specificity of certain<br />
substances when contesting the validity of next-of-kin reporting versus<br />
toxicology reports.<br />
Introduction: Collection of substance use information for those<br />
who died unexpectedly often rely on proxy respondents or toxicology<br />
reports. Past research have examined surrogate reporting about the<br />
deceased characteristics. However, the direct assessment of proxy<br />
reporting of substance use versus toxicology report were rarely investigated.<br />
The purpose of this study were: 1) to use toxicology report as a<br />
gold standard to evaluate the validity of proxy reporting of substance<br />
use, and 2) to identify which drug groups that are more likely to be accurately<br />
reported by the surrogate.<br />
* Presenting Author<br />
Methods: The data for this study were obtained from the 1993<br />
National Mortality Followback Survey (NMFS) conducted by the<br />
National Center for Health Statistics, Centers for Disease Control and<br />
Prevention. With the permission from next-of-kin of the deceased, questionnaire<br />
data were linked to 3483 toxicology report collected from 1265<br />
medical examiner/coroner offices. Ten items that asking the deceased<br />
substance use behavior were selected from questionnaire and compared<br />
with toxicology report. In the interview questionnaire, substances were<br />
grouped into nine drug categories : alcohol, pain killer, sedative, tranquilizer,<br />
antidepressant, stimulant, cocaine, marijuana, and methadone.<br />
Sensitivity and specificity test were used to evaluate the validity of nextof-kin<br />
reporting. We defined sensitivity is the toxicology report GC/MS<br />
confirm positive of a substance used and next-of-kin also reported yes to<br />
that substance for the deceased. Specificity is the toxicology report<br />
GC/MS confirm negative of a substance used and next-of-kin also<br />
reported no to that substance for the deceased.<br />
Results and Discussion: The study results in the table below<br />
demonstrated that methadone and painkillers such as morphine, codeine<br />
and propoxyphene had 100% sensitivity. High sensitivity reflects that<br />
immunoassay procedures and confirmation techniques for these two categories<br />
of substance that were well developed and routinely executed for<br />
their identification in the laboratory. However, the sensitivity for other<br />
categories of substance use was low. The possible explanation for low<br />
sensitivity could be: 1) inability of the laboratory to detect substances<br />
that were not routinely screened and confirmed; 2) each substance has<br />
an unique halflife.<br />
Consumption of substances such as methamphetamine, cocaine, or<br />
alcohol few days prior to death often provides a negative lab result; 3)<br />
small quantity of substance use frequently causes a lab result below the<br />
detection limit; 4) detection time also varies depending upon analytical<br />
method used, drug metabolism, individual’s physical condition, fluid<br />
intake, and method and frequency of substance ingestion prior to death.<br />
Furthermore, cutoff values for positive substance vary from one laboratory<br />
to another. Regarding specificity, the survey revealed an average<br />
76% specificity indicating that proxy reporting of substance use has<br />
some degree of scientific certainty in general. However none of the individual<br />
categories of substance reached 100% specificity, meaning proxy<br />
respondents did not know whether the decedents had used substance<br />
prior to their death. Alcohol, on the other hand, has the lowest specificity.<br />
It is probably associated with proxy’s social, financial, psychological<br />
and legal implications. In conclusion, our study showed that both<br />
the toxicology report and proxy reporting provided important information<br />
in identifying forensic relevance for those who died unexpectedly.<br />
Nevertheless, shortfalls of each reporting system should be<br />
cautiously taken into consideration in result interpretation.<br />
Sensitivity Specificity<br />
Alcohol 0.93 0.26<br />
Pain Killer 1.00 0.73<br />
Sedative 0.36 0.88<br />
Tranquilizer 0.47 0.85<br />
Antidepressant 0.60 0.75<br />
Stimulant 0.41 0.93<br />
Cocaine 0.59 0.85<br />
Marijuana 0.58 0.80<br />
Methadone 1.00 0.90<br />
Validity, Toxicology Report, Surrogate Reporting<br />
212